BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 27886547)

  • 1. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S; D'hooghe M
    Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial drug discovery: recent progress and future directions.
    Calderón F; Wilson DM; Gamo FJ
    Prog Med Chem; 2013; 52():97-151. PubMed ID: 23384667
    [No Abstract]   [Full Text] [Related]  

  • 5. New approaches in antimalarial drug discovery and development: a review.
    Aguiar AC; Rocha EM; Souza NB; França TC; Krettli AU
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):831-45. PubMed ID: 23147137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins.
    Madhav H; Hoda N
    Eur J Med Chem; 2021 Jan; 210():112955. PubMed ID: 33131885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs.
    Delves MJ
    Future Med Chem; 2012 Dec; 4(18):2251-63. PubMed ID: 23234549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Development Process for Discovery and Clinical Advancement of Modern Antimalarials.
    Ashton TD; Devine SM; Möhrle JJ; Laleu B; Burrows JN; Charman SA; Creek DJ; Sleebs BE
    J Med Chem; 2019 Dec; 62(23):10526-10562. PubMed ID: 31385706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria today: advances in management and control.
    Pannu AK
    Trop Doct; 2019 Jul; 49(3):160-164. PubMed ID: 31060446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio.
    Chaparro MJ; Calderón F; Castañeda P; Fernández-Alvaro E; Gabarró R; Gamo FJ; Gómez-Lorenzo MG; Martín J; Fernández E
    ACS Infect Dis; 2018 Apr; 4(4):568-576. PubMed ID: 29320160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrocene-based antimalarials.
    Roux C; Biot C
    Future Med Chem; 2012 Apr; 4(6):783-97. PubMed ID: 22530641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarials from nature.
    Kaur K; Jain M; Kaur T; Jain R
    Bioorg Med Chem; 2009 May; 17(9):3229-56. PubMed ID: 19299148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drug development: past to present scenario.
    Dhanawat M; Das N; Nagarwal RC; Shrivastava SK
    Mini Rev Med Chem; 2009 Oct; 9(12):1447-69. PubMed ID: 19929818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hits, leads and drugs against malaria through diversity-oriented synthesis.
    Dandapani S; Comer E; Duvall JR; Munoz B
    Future Med Chem; 2012 Dec; 4(18):2279-94. PubMed ID: 23234551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.